Knock down of caveolin-1 affects morphological and functional hallmarks of human endothelial cells

Journal of Cellular Biochemistry

Volumn 114, Issue 8, 2013, Pages 1843-1851

  Madaro, Luca ^a   Antonangeli, Fabrizio ^a,b   Favia, Annarita ^a   Esposito, Bianca ^a   Biamonte, Filippo ^c   Bouché, Marina ^a   Ziparo, Elio ^a   Sica, Gigliola ^c   Filippini, Antonio ^a   D'Alessio, Alessio ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

ANGIOGENESIS; CAVEOLIN 1; ENDOTHELIAL CELLS; MMP; STEREOLOGY

Indexed keywords

CAVEOLIN 1; GELATINASE A; PROTEIN KINASE B; SMALL INTERFERING RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL MIGRATION; CELL SIZE; CELL STRUCTURE; CELL SURFACE; CELL VOLUME; CONTROLLED STUDY; CYTOLOGY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEREOLOGY; STRESS FIBER;

CAVEOLIN 1; CELL LINE; CELL MOVEMENT; COLLAGENASES; ENDOTHELIAL CELLS; G1 PHASE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; S PHASE; SIGNAL TRANSDUCTION;

EID: 84879171327     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24526     Document Type: Article

References (43)

1. Bai L, Deng X, Li Q, Wang M, An W, Deli A, Gao Z, Xie Y, Dai Y, Cong YS,. 2012. Down-regulation of the cavin family proteins in breast cancer. J Cell Biochem 113: 322-328.
2. Bernatchez P, Sharma A, Bauer PM, Marin E, Sessa WC,. 2011. A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice. J Clin Invest 121: 3747-3755.
3. Burgermeister E, Liscovitch M, Rocken C, Schmid RM, Ebert MP,. 2008. Caveats of caveolin-1 in cancer progression. Cancer Lett 268: 187-201.
4. Chidlow JH, Jr., Sessa WC,. 2010. Caveolae, caveolins, and cavins: Complex control of cellular signalling and inflammation. Cardiovasc Res 86: 219-225.
5. D'Alessio A, Al-Lamki RS, Bradley JR, Pober JS,. 2005. Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. Am J Pathol 166: 1273-1282.
6. D'Alessio A, Kluger MS, Li JH, Al-Lamki R, Bradley JR, Pober JS,. 2010. Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells. J Biol Chem 285: 23868-23879.
7. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, Elvassore N, Piccolo S,. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474: 179-183.
8. Edgell CJ, McDonald CC, Graham JB,. 1983. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80: 3734-3737.
9. Feng X, Gaeta ML, Madge LA, Yang JH, Bradley JR, Pober JS,. 2001. Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J Biol Chem 276: 8341-8349.
10. Fernandez-Rojo MA, Restall C, Ferguson C, Martel N, Martin S, Bosch M, Kassan A, Leong GM, Martin SD, McGee SL, Muscat GE, Anderson RL, Enrich C, Pol A, Parton RG,. 2012. Caveolin-1 orchestrates the balance between glucose and lipid-dependent energy metabolism: Implications for liver regeneration. Hepatology 55: 1574-1584.
11. Gambara G, Billington RA, Debidda M, D'Alessio A, Palombi F, Ziparo E, Genazzani AA, Filippini A,. 2008. NAADP-induced Ca(2+) signaling in response to endothelin is via the receptor subtype B and requires the integrity of lipid rafts/caveolae. J Cell Physiol 216: 396-404.
12. Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C,. 2010. Caveolinopathies: From the biology of caveolin-3 to human diseases. Eur J Hum Genet 18: 137-145.
13. Glenney JR, Jr., Soppet D,. 1992. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 89: 10517-10521.
14. Gundersen HJ,. 1988. The nucleator. J Microsc 151: 3-21.
15. Hansen CG, Nichols BJ,. 2010. Exploring the caves: Cavins, caveolins and caveolae. Trends Cell Biol 20: 177-186.
16. Hermant B, Desroches-Castan A, Dubessay ML, Prandini MH, Huber P, Vittet D,. 2007. Development of a one-step embryonic stem cell-based assay for the screening of sprouting angiogenesis. BMC Biotechnol 7: 20.
17. Hildebrand JD, Schaller MD, Parsons JT,. 1993. Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol 123: 993-1005.
18. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, Walser P, Abankwa D, Oorschot VM, Martin S, Hancock JF, Parton RG,. 2008. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132: 113-124.
19. Kerbel R, Folkman J,. 2002. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2: 727-739.
20. Liang CC, Park AY, Guan JL,. 2007. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333.
21. Livak KJ, Schmittgen TD,. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
22. Nalla AK, Gorantla B, Gondi CS, Lakka SS, Rao JS,. 2010. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Ther 17: 599-613.
23. Newby AC,. 2012. Matrix metalloproteinase inhibition therapy for vascular diseases. Vascul Pharmacol 56: 232-244.
24. Parsons JT, Slack-Davis J, Tilghman R, Roberts WG,. 2008. Focal adhesion kinase: Targeting adhesion signaling pathways for therapeutic intervention. Clin Cancer Res 14: 627-632.
25. Parton RG, Simons K,. 2007. The multiple faces of caveolae. Nat Rev Mol Cell Biol 8: 185-194.
26. Pober JS, Sessa WC,. 2007. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7: 803-815.
27. Qi M, Liu Y, Freeman MR, Solomon KR,. 2009. Cholesterol-regulated stress fiber formation. J Cell Biochem 106: 1031-1040.
28. Quest AF, Lobos-Gonzalez L, Nunez S, Sanhueza C, Fernandez JG, Aguirre A, Rodriguez D, Leyton L, Torres V,. 2012. The caveolin-1 connection to cell death and survival. Curr Mol Med 13: 266-281.
29. Reglero-Real N, Marcos-Ramiro B, Millan J,. 2012. Endothelial membrane reorganization during leukocyte extravasation. Cell Mol Life Sci 69: 3079-3099.
30. Romano F, Gambara G, De Cesaris P, Ziparo E, Palombi F, Filippini A,. 2007. Endothelin induces functional hypertrophy of peritubular smooth muscle cells. J Cell Physiol 212: 264-273.
31. Roy UK, Henkhaus RS, Loupakis F, Cremolini C, Gerner EW, Ignatenko NA,. 2013. Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis. Int J Cancer. DOI: 10.1002/ijc.28001
32. Samuel CE,. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809.
33. Schaller MD,. 2010. Cellular functions of FAK kinases: Insight into molecular mechanisms and novel functions. J Cell Sci 123: 1007-1013.
34. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP,. 1996. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 93: 131-135.
35. Schmitz C, Schuster D, Niessen P, Korr H,. 1999. No difference between estimated mean nuclear volumes of various types of neurons in the mouse brain obtained on either isotropic uniform random sections or conventional frontal or sagittal sections. J Neurosci Methods 88: 71-82.
36. Sengupta D,. 2012. Cholesterol modulates the structure, binding modes, and energetics of caveolin-membrane interactions. J Phys Chem B 116: 14556-14564.
37. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BRG,. 2003. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5: 834-839.
38. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP,. 1996. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271: 15160-15165.
39. Spisni E, Bianco MC, Griffoni C, Toni M, D'Angelo R, Santi S, Riccio M, Tomasi V,. 2003. Mechanosensing role of caveolae and caveolar constituents in human endothelial cells. J Cell Physiol 197: 198-204.
40. Stetler-Stevenson WG,. 1999. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest 103: 1237-1241.
41. Thiele C, Hannah MJ, Fahrenholz F, Huttner WB,. 2000. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2: 42-49.
42. Vasile E, Qu H, Dvorak HF, Dvorak AM,. 1999. Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels. J Histochem Cytochem 47: 159-167.
43. Wu H-T, Lin S-H, Chen Y-H,. 2005. Inhibition of cell proliferation and in vitro markers of angiogenesis by indole-3-carbinol, a major indole metabolite present in cruciferous vegetables. J Agric Food Chem 53: 5164-5169.